These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22881436)

  • 1. Solvation in hydrofluoroalkanes: How can ethanol help?
    Conti DS; Grashik J; Yang L; Wu L; da Rocha SR
    J Pharm Pharmacol; 2012 Sep; 64(9):1236-44. PubMed ID: 22881436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding solvation in hydrofluoroalkanes: ab initio calculations and chemical force microscopy.
    Wu L; Peguin RP; da Rocha SR
    J Phys Chem B; 2007 Jul; 111(28):8096-104. PubMed ID: 17580855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding solvation in the low global warming hydrofluoroolefin HFO-1234ze propellant.
    Yang L; da Rocha SR
    J Phys Chem B; 2014 Sep; 118(36):10675-87. PubMed ID: 25137437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPFP, a model propellant for pMDIs.
    Rogueda PG
    Drug Dev Ind Pharm; 2003 Jan; 29(1):39-49. PubMed ID: 12602491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles.
    Chokshi U; Selvam P; Porcar L; da Rocha SR
    Int J Pharm; 2009 Mar; 369(1-2):176-84. PubMed ID: 19028557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics.
    Selvam P; Bharatwaj B; Porcar L; da Rocha SR
    Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
    Zhu B; Traini D; Chan HK; Young PM
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems.
    Ooi J; Gaisford S; Boyd BJ; Young PM; Traini D
    Int J Pharm; 2014 Jan; 461(1-2):301-9. PubMed ID: 24325938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ester group: how hydrofluoroalkane-philic is it?
    Peguin RP; Wu L; da Rocha SR
    Langmuir; 2007 Jul; 23(16):8291-4. PubMed ID: 17602576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of molecular weight and end-group nature on the solubility of ethylene oxide oligomers in 2H, 3H-decafluoropentane and its fully fluorinated analogue, perfluoropentane.
    Cote M; Rogueda PG; Griffiths PC
    J Pharm Pharmacol; 2008 May; 60(5):593-9. PubMed ID: 18416935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty years of HFA pMDI patents: facts and perspectives.
    Rogueda P; Lallement A; Traini D; Iliev I; Young PM
    J Pharm Pharmacol; 2012 Sep; 64(9):1209-16. PubMed ID: 22881434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant design for the 1,1,1,2-tetrafluoroethane-water interface: ab initio calculations and in situ high-pressure tensiometry.
    Selvam P; Peguin RP; Chokshi U; da Rocha SR
    Langmuir; 2006 Oct; 22(21):8675-83. PubMed ID: 17014104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting physical stability in pressurized metered dose inhalers via dwell and instantaneous force colloidal probe microscopy.
    D'Sa D; Chan HK; Chrzanowski W
    Eur J Pharm Biopharm; 2014 Sep; 88(1):129-35. PubMed ID: 25058596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopy.
    Hoe S; Young PM; Rogueda P; Traini D
    AAPS PharmSciTech; 2008; 9(2):605-11. PubMed ID: 18459053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Dixit S; Malick WA; Madan PL
    Drug Dev Ind Pharm; 1998 Apr; 24(4):345-52. PubMed ID: 9876594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
    D'Sa D; Chan HK
    Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants.
    Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C
    Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants.
    Saleem IY; Smyth HD
    Biomed Res Int; 2013; 2013():574310. PubMed ID: 23984381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.